Search Our Website:
May 18 2021
2:45 PM - 3:45 PM

Barbara Binzak Blumenfeld, shareholder in the firm's Life Sciences Industry Group, is moderating a panel at the 2021 FDLI Annual Conference, “Key Issues in Regenerative Medicine Regulation and Approval.” The panel will address multiple regulatory aspects of regenerative medicine, from product characterization to product manufacturing to FDA enforcement.